RecruitingNot ApplicableNCT06731166

Effectiveness of Video Monitoring and Care Transition for Heart Failure Patients (EVIT-HF): Randomized Clinical Trial

Sponsor

Federal University of Uberlandia

Enrollment

368 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)

Summary

The goal of this clinical trial is to measure the effectiveness of video monitoring associated with the transition of care for patients with heart failure. The main questions it aims to answer is: Is video monitoring superior to monitoring via audio calls in patients with heart failure? Researchers will compare monitoring by video to a monitoring by audio to see if drug videomonitoring works to improve selfcare in heart failure and other outocomes. Participants will: intervention group receive video calls guided by cardiologist nurses at 7, 30, 60, 180 and 365 days after hospital discharge. the control group will receive audio calls for data collection, at the same time mentioned.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a video monitoring and remote care program after hospital discharge can reduce readmissions and improve outcomes for people hospitalized with heart failure (specifically the type where the heart muscle is weakened and pumps poorly). **You may be eligible if...** - You are 18 or older - You have been admitted to the hospital for worsening heart failure with reduced ejection fraction (the heart pumps less than 40% of its blood volume) - Your diagnosis was confirmed by an echocardiogram in the last 3 months - You have access to a smartphone or tablet with internet **You may NOT be eligible if...** - You are on a heart transplant waiting list - You had bypass surgery (CABG) in the last 3 months - You are in palliative (end-of-life comfort) care - Your life expectancy is less than 1 year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.